PAD-IN-3 (Compound 16) is a potent dual inhibitor of peptidylarginine deiminase 4 (PAD4) and PAD1, with IC50 values of 0.204 µM and 0.273 µM, respectively. It has potential applications in the research of citrullination-related diseases such as cancer and autoimmune disorders.
Target:
PAD
* VAT and and shipping costs not included. Errors and price changes excepted
